Accuray to Host Analyst Event at the American Society of Radiation Oncology Meeting on September 29, 2025
Accuray (NASDAQ: ARAY) announced it will host an analyst and investor event during the American Society of Radiation Oncology (ASTRO) Annual Meeting in San Francisco on September 29, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Accuray (NASDAQ: ARAY) announced it will host an analyst and investor event during the American Society of Radiation Oncology (ASTRO) Annual Meeting in San Francisco on September 29, 2025. The hybrid event, starting at 1:30 PM PT, will feature global thought leaders discussing adaptive radiotherapy in radiation medicine.
The presentation will cover key topics including the adaptive radiotherapy spectrum, programmatic vision, practice integration, workflow realities, and motion management from a global perspective. Both in-person and virtual attendees must register by September 25, 2025.
Details
News Market Reaction – ARAY
On Sep 12, the first trading day after this news, ARAY closed 1.26% below the previous close. That session’s volume was 1.9x the stock’s average daily volume.
Data tracked by StockTitan Argus for the Sep 12 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Event Will Feature Global KOLs Sharing Their Perspectives on the Role of Adaptive Radiotherapy in Radiation Medicine
Analysts participating in the event will have a unique opportunity to hear first-hand from global thought leaders who will share their perspectives on the role of adaptive radiotherapy in radiation medicine. Topics include:
- The Adaptive Radiotherapy Spectrum & Programmatic Vision
- Integration of Adaptive Radiotherapy into Practice & Workflow Realities
- Motion Management & Imaging Leadership: The Global Perspective
Both in-person and virtual guests must register in advance to participate in the Accuray meeting. Please RSVP here by September 25, 2025.
About Accuray
Accuray Incorporated (Nasdaq: ARAY) is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions that are designed to deliver radiation treatments for even the most complex cases – while making commonly treatable cases even easier – to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Madison,
Investor Contact
Aman Patel, CFA
Investor Relations, ICR Healthcare
+1 (443) 450-4191
aman.patel@westwicke.com
Media Contact
Beth Kaplan
Public Relations Director, Accuray
bkaplan@accuray.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/accuray-to-host-analyst-event-at-the-american-society-of-radiation-oncology-meeting-on-september-29-2025-302554133.html
SOURCE Accuray Incorporated
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.